Repro Med Systems Stock In The News

KRMD Stock  USD 2.77  0.07  2.59%   
Our overall analysis of Repro Med's news coverage and content from conventional and social sources shows investors' bearish mood towards Repro Med Systems. The specific impact of Repro Med news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Repro Med's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Repro Med headlines in addition to utilizing other, more conventional financial analysis modules. Check out Repro Med Backtesting and Repro Med Hype Analysis.

Repro Med Today Top News and Investor Outlook

Yahoo News
KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates
https://finance.yahoo.com/news/koru-medical-systems-inc-announces-211500783.html
 Neutral
Yahoo News
KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023
https://finance.yahoo.com/news/koru-medical-systems-report-second-200500155.html
 Bullish
Yahoo News
KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic
https://finance.yahoo.com/news/koru-medical-systems-announces-novel-200500127.html
 Bullish
Yahoo News
KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes
https://finance.yahoo.com/news/koru-medical-systems-inc-announces-110100033.html
 Bullish
Yahoo News
KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer
https://finance.yahoo.com/news/koru-medical-systems-inc-names-110500050.html
 Bullish
Yahoo News
KORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2023 Earnings Call Transcript
https://finance.yahoo.com/news/koru-medical-systems-inc-nasdaq-191535944.html
 Bullish
Yahoo News
KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results
https://finance.yahoo.com/news/koru-medical-systems-inc-announces-200100384.html
 Bullish
Yahoo News
KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023
https://finance.yahoo.com/news/koru-medical-systems-report-first-110100167.html
 Bullish
Yahoo News
KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022
https://finance.yahoo.com/news/koru-medical-systems-announces-2022-210100270.html
 Bullish
Yahoo News
KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
https://finance.yahoo.com/news/koru-medical-systems-report-fourth-210100086.html
 Bullish

Repro Med Systems Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Repro and other traded companies coverage with news coverage. We help investors stay connected with Repro headlines for the 15th of March 2025 to make an informed investment decision based on correlating the impacts of news items on Repro Stock performance. Please note that trading solely based on the Repro Med Systems hype is not for everyone as timely availability and quick action are needed to avoid losses.
Repro Med's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Repro Med Systems investors visualize upcoming and past events in order to time the market based on Repro Med Systems noise-free hype analysis.
Repro Med stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Repro earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Repro Med that are available to investors today. That information is available publicly through Repro media outlets and privately through word of mouth or via Repro internal channels. However, regardless of the origin, that massive amount of Repro data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Repro Med news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Repro Med relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Repro Med's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Repro Med alpha.

Repro Largest EPS Surprises

Earnings surprises can significantly impact Repro Med's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-12-31
2024-12-31-0.0233-0.020.003314 
2019-04-30
2019-03-310.010.01960.009696 
2024-03-13
2023-12-31-0.04-0.030.0125 
2023-08-09
2023-06-30-0.06-0.050.0116 
2022-03-02
2021-12-31-0.03-0.020.0133 
2021-08-11
2021-06-30-0.02-0.03-0.0150 
View All Earnings Estimates

Repro Med Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Repro Med Systems Stock. Current markets are strongly bullish. About 93% of major world exchanges and indexes are currently up. See today's market update for more information.
insidermonkey News
13th of March 2025
KORU Medical Systems, Inc. Q4 2024 Earnings Call Transcript
at insidermonkey.com 
news
11th of March 2025
KORU Medical Systems Projected to Post Earnings on Wednesday
at thelincolnianonline.com 
Simply Wall St News at Macroaxis
5th of March 2025
Acquisition by Manko Joseph M. Jr. of 351948 shares of Repro Med subject to Rule 16b-3
at simplywall.st 
businesswire News
19th of February 2025
KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on Marc...
at businesswire.com 
Gurufocus Stories at Macroaxis
14th of February 2025
Acquisition by Wholihan Edward of 37 shares of Repro Med at 3.81 subject to Rule 16b-3
at gurufocus.com 
businesswire News
30th of January 2025
KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indic...
at businesswire.com 
Macroaxis News
23rd of January 2025
Acquisition by Cascella Robert of 19000 shares of Repro Med at 2.607 subject to Rule 16b-3
at MacroaxisInsider 
businesswire News
13th of January 2025
KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results Achieve...
at businesswire.com 
Macroaxis News
3rd of January 2025
Acquisition by French Donna of 37 shares of Repro Med at 3.81 subject to Rule 16b-3
at MacroaxisInsider 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Repro Med in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Repro Med's short interest history, or implied volatility extrapolated from Repro Med options trading.
When determining whether Repro Med Systems is a strong investment it is important to analyze Repro Med's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Repro Med's future performance. For an informed investment choice regarding Repro Stock, refer to the following important reports:
Check out Repro Med Backtesting and Repro Med Hype Analysis.
You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Repro Med. If investors know Repro will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Repro Med listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.66)
Earnings Share
(0.26)
Revenue Per Share
0.699
Quarterly Revenue Growth
0.168
Return On Assets
(0.14)
The market value of Repro Med Systems is measured differently than its book value, which is the value of Repro that is recorded on the company's balance sheet. Investors also form their own opinion of Repro Med's value that differs from its market value or its book value, called intrinsic value, which is Repro Med's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Repro Med's market value can be influenced by many factors that don't directly affect Repro Med's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Repro Med's value and its price as these two are different measures arrived at by different means. Investors typically determine if Repro Med is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Repro Med's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.